1 Min Read
Aug 10 (Reuters) - Imprimis Pharmaceuticals Inc
* Imprimis pharmaceuticals announces second quarter 2017 financial results
* Q2 revenue rose 40 percent to $6.9 million
* Q2 earnings per share $0.07 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.